Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: Cluster randomised controlled trial

British Journal of Psychiatry

Volumn 185, Issue AUG., 2004, Pages 157-162

  Gray, Richard ^a   Wykes, Til ^a   Edmonds, Melisa ^a   Leese, Morven ^a   Gournay, Kevin ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COMMUNITY MENTAL HEALTH; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MONITORING; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MENTAL DISEASE; NEGATIVE SYNDROME; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; POSITIVE SYNDROME; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; SINGLE BLIND PROCEDURE; TRAINING;

ADULT; ANTIPSYCHOTIC AGENTS; CLUSTER ANALYSIS; COMMUNITY HEALTH NURSING; EDUCATION, NURSING, CONTINUING; HUMANS; INSERVICE TRAINING; LONDON; PATIENT COMPLIANCE; SCHIZOPHRENIA; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 4043139305     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.185.2.157     Document Type: Article

References (18)

1. Brooker, C. & White, F. (1997) The Fourth Quinquennial National Community Mental Health Nursing Census of England and Wales. Manchester: University of Manchester.
2. Day, J. C., Wood, G., Dewey, M., et al (1995) A self-rating scale or measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. British Journal of Psychiatry, 166, 650-653.
3. Donner, A. & Klar, N. (2000) Design and Analysis of Cluster Randomization Trials in Health Research. London: Arnold.
4. Gray, R. (2001) A randomised controlled trial of medication management training. PhD thesis. Institute of Psychiatry, King's College London.
5. Gray, R., Wykes, T. & Gournay, K. (2003) Effect of medication management training on community mental health nurses clinical skills. International Journal of Nursing Studies, 40, 163-169.
6. Haynes, R. B., McDonald, H., Garg, A. X., et al (2002) Interventions for helping patients to follow prescriptions for medications (Cochrane Review). In The Cochrane Library, Issue 2. Oxford: Update Software.
7. Hogan, T. P., Awad, A. G. & Eastwood, R. (1983) A self-report scale predictive of drug compliance in schizophrenia: reliability and discriminative validity. Psychological Medicine, 13, 177-183.
8. Kay, S. R., Opler, L. A. & Lindenmayer, J.-P. (1989) The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. British Journal of Psychiatry, 155 (suppl. 7), 59-65.
9. Kemp, R. & David, A. (1996) Psychosis: insight and compliance. Current Opinion in Psychiatry, 8, 357-361.
10. Kemp, R., Hayward, P. & David, A. (1997) Compliance Therapy Manual. London: Bethlem and Maudsley NHS Trust.
11. Kemp, R., Kirov, G., Everitt, P., et al (1998) Randomised controlled trial of compliance therapy: 18-month follow-up. British Journal of Psychiatry, 172, 413-419.
12. O'Donnell, C., Donohoe, G., Sharkey, L., et al (2003) Compliance therapy: a randomised controlled trial in schizophrenia. BMJ, 327, 834-840.
13. Overall, J. E. & Gorham, D. R. (1942) Brief Psychiatric Rating Scale. Psychological Reports, 10, 799-812.
14. Vallis, T. M., Shaw, B. F. & Dobson, K. S. (1984) The cognitive therapy scale: psychometric properties. Journal of Consulting and Clinical Psychology, 54, 381-385.
15. Wahlbeck, K., Tuunainen, A., Ahokas, A., et al (2001) Dropout rates in randomised antipsychotic drug trials. Psychopharmacology, 155, 230-233.
16. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: WHO.
17. World Health Organization (1993) Anatomical Therapeutic Chemical (ATC) Classification. In Guidelines for ATC Classification (4th edn), pp. 23-185. Geneva: WHO.
18. World Health Organization (2003) Adherence to Long-term Therapies. Evidence for Action. Geneva: WHO.